Why compounded tirzepatide sometimes requires reconstitution
Branded tirzepatide (Mounjaro, Zepbound) is sold in pre-filled autoinjector pens — the medication is already in solution and requires no preparation before injection. Compounded tirzepatide from a 503A pharmacy may arrive differently depending on the pharmacy’s formulation:
- Pre-mixed solution: Some pharmacies dispense tirzepatide already dissolved in bacteriostatic water, ready to draw and inject. No reconstitution is required.
- Lyophilized (freeze-dried) powder: Other pharmacies supply a powder vial that must be reconstituted with a diluent before use. This form has longer shelf stability before mixing and is common in multi-dose vials designed to last several weeks.
Your pharmacy label, prescription instructions, and patient education materials specify which form you have received and whether reconstitution is required.
How do you read a tirzepatide reconstitution chart?
A reconstitution chart is a lookup table with three columns:
- Diluent volume added: The amount of bacteriostatic water (in mL) you add to the powder vial.
- Resulting concentration: The strength of the mixed solution (in mg/mL) after the diluent is added.
- Injection volume for a given dose: The volume (in mL) you draw into the syringe to deliver your prescribed milligram dose.
The fundamental math is straightforward. If you add 2 mL of bacteriostatic water to a 10 mg powder vial, you get a 5 mg/mL solution. A 2.5 mg dose requires 0.5 mL. A 5 mg dose requires 1 mL. The chart automates this calculation for a range of vial sizes and diluent volumes.
Example reconstitution chart (10 mg vial)
| Bacteriostatic water added | Concentration (mg/mL) | 2.5 mg dose (mL) | 5 mg dose (mL) |
|---|---|---|---|
| 1 mL | 10 mg/mL | 0.25 mL | 0.50 mL |
| 2 mL | 5 mg/mL | 0.50 mL | 1.00 mL |
| 4 mL | 2.5 mg/mL | 1.00 mL | 2.00 mL |
Example only — based on a 10 mg vial. Always use the chart or instructions from your specific pharmacy for your specific vial. Your clinician sets the diluent volume and dose.
The critical constraint: your chart must match your actual vial. If your pharmacy supplies a 20 mg vial and your chart assumes a 10 mg vial, every calculation will be wrong by a factor of two. Always use a chart — or do the math — from your specific pharmacy’s dispensing information for your specific vial.
A reconstitution chart tells you the volume to draw — it never tells you the dose; that judgment belongs to your clinician.
Step-by-step reconstitution process
Your pharmacy provides written reconstitution instructions with every lyophilized vial. The general process follows these steps:
- Gather supplies: The tirzepatide powder vial, a sealed vial of bacteriostatic water for injection (BWI), the appropriate syringe and needles, and an alcohol wipe.
- Clean surfaces: Wipe the rubber septums of both the BWI vial and the tirzepatide vial with alcohol. Let them dry for 30 seconds.
- Draw the diluent:Using a clean syringe, draw the volume of BWI specified in your pharmacy’s instructions (e.g., 2 mL for a standard preparation).
- Add diluent to powder: Insert the syringe needle into the tirzepatide vial and inject the BWI slowly down the side of the vial, not directly onto the powder cake. Injecting onto the powder can cause foaming and degradation.
- Gentle inversion, not agitation: Gently roll or invert the vial to mix until the powder is fully dissolved. Do not shake. Vigorous agitation denatures peptides.
- Inspect the solution: The reconstituted solution should be clear, colorless or very slightly yellow, and free of particulate matter. Do not use if you see cloudiness, discoloration, or visible particles.
- Label and refrigerate: Note the reconstitution date on the vial. Store refrigerated and use within the window your pharmacy specifies (typically 28 days for BWI-reconstituted preparations).
Why does your dose come from your clinician, not the chart?
Reconstitution math tells you the injection volume for a dose; it does not tell you what dose to inject. That determination belongs to your prescribing clinician, and the reasons go beyond safety conventions:
- Titration protocol: Tirzepatide is started at a low dose (2.5 mg) and titrated upward based on individual tolerance and response. Moving too quickly causes nausea, vomiting, and constipation; moving too slowly slows progress toward clinical goals. The right schedule is individual.
- Individual response variation: Patients differ substantially in how they respond to each dose level. A clinician who reviews your follow-up data can make informed adjustments; a chart cannot.
- Contraindications and interactions:A clinician reviews your full history, including medications that might interact with tirzepatide’s effects on gastric motility, insulin secretion, and blood pressure.
Use the reconstitution chart as the calculation tool it is, then follow your prescription for the dose itself.
Storage and stability after reconstitution
Properly stored reconstituted tirzepatide is stable for up to 28 days under refrigeration when bacteriostatic water is used as the diluent. Bacteriostatic water contains 0.9% benzyl alcohol, which is a preservative that inhibits bacterial growth in the vial between uses. This is why BWI is the standard choice for multi-dose compounded vials.
Key storage rules:
- Refrigerate between 2–8°C (36–46°F) after reconstitution
- Do not freeze the mixed solution; freezing can denature the peptide
- Protect from light; store in the original box if possible
- Discard on the date your pharmacy specifies or if the solution appears abnormal
Frequently asked questions
What is a tirzepatide reconstitution chart?
A reconstitution chart is a reference table that maps the volume of diluent (typically bacteriostatic water) added to a lyophilized (freeze-dried) powder vial of tirzepatide to the resulting concentration and the injection volume needed for a specific dose. It is a math aid, not a dosing guide.
Does compounded tirzepatide always need to be reconstituted?
Not always. Some 503A compounding pharmacies dispense tirzepatide in pre-mixed solution form, which does not require reconstitution. Others provide lyophilized powder that must be mixed with bacteriostatic water before use. Your prescription and pharmacy instructions specify which form you have received.
What diluent is used to reconstitute tirzepatide?
Bacteriostatic water for injection (BWI) is the standard diluent. It contains 0.9% benzyl alcohol, which inhibits microbial growth in multi-dose vials. Sterile water for injection can also be used but does not have preservative properties and must be used immediately after mixing if employed for a single injection.
Who sets my tirzepatide dose?
Your prescribing clinician determines your starting dose and any titration schedule. A reconstitution chart helps you calculate the injection volume that delivers your prescribed dose given your vial concentration — it does not and should not be used to self-select a dose.
How do I calculate injection volume from vial concentration?
The formula is: injection volume (mL) = prescribed dose (mg) divided by concentration (mg/mL). For example, if your vial is reconstituted to 5 mg/mL and your dose is 2.5 mg, you inject 0.5 mL. Your pharmacy label and clinician instructions should confirm this calculation.
How should I store reconstituted tirzepatide?
Reconstituted tirzepatide should be stored in the refrigerator (2–8°C / 36–46°F) and protected from light. Do not freeze the mixed solution. Bacteriostatic water extends stability in the vial for up to 28 days under refrigeration, but confirm the specific expiry with your pharmacy.